Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients

BACKGROUND: The purpose of the study was to evaluate the 2-year outcome and predictive factors of treat-and-extend aflibercept in patients with eyes affected by typical neovascular age-related macula degenelation (t-AMD) or polypoidal choroidal vasculopathy (PCV), who were switched from ranibizumab....

Descripción completa

Detalles Bibliográficos
Autores principales: Azuma, Keiko, Asaoka, Ryo, Matsuda, Aya, Lee, Jihee, Shimizu, Kimiko, Inui, Hiroko, Murata, Hiroshi, Ogawa, Asako, Yamamoto, Motoshi, Inoue, Tatsuya, Obata, Ryo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120579/
https://www.ncbi.nlm.nih.gov/pubmed/30214143
http://dx.doi.org/10.2147/OPTH.S172115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120579/
https://www.ncbi.nlm.nih.gov/pubmed/30214143
http://dx.doi.org/10.2147/OPTH.S172115

Ejemplares similares